Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02071862
Recruitment Status : Completed
First Posted : February 26, 2014
Last Update Posted : February 17, 2020
Sponsor:
Information provided by (Responsible Party):
Calithera Biosciences, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2019
Actual Study Completion Date : March 2019